Cytotoxics
Parenteral cytotoxic agents are among the most highly sophisticated and sensitive drugs to handle and produce. Our barrier technology ensures your cytotoxic product is manufactured under precisely controlled temperature, relative humidity, and pressure conditions, in a clean-room Grade A environment. Benefits of closed-system manufacturing include:
- Minimized contamination risks
- High-quality product development and manufacturing
- Employee and environmental safety
At our recently expanded cytotoxic manufacturing facility in Halle/Westfalen, Germany, all your cytotoxic parenteral needs are handled at one manufacturing facility, which allows us to create efficient processing solutions to fit your compound. A dedicated cytotoxic focus helps manage capacity and flexibility, which are critical for maintaining reliable product supply.
For cytotoxic molecules, we offer the following capabilities:
- Liquid and dry-powder filling
- Clinical- and commercial-scale lyophilizers
- Sterile Crystallization
- Lyophilization cycle development
- Antibody-Drug Conjugates (ADCs)
Integrated support services for cytotoxics include:
- Stability storage, validation and documentation
- Technology transfer
- Analytical and microbiological services
- Packaging and kitting
